Japan We have evolved well beyond the traditional CRO model Global biopharma companies are looking at Japan through a different lens, seeking partners that can navigate an increasingly complex regulatory landscape while supporting integrated development across Asia. At the heart of that evolution is CMIC, whose President and Representative Executive Officer,…
APAC For two decades the case for running a clinical trial in Asia was essentially arithmetic: the same study, for less money. That argument has not gone away, but it is no longer the one APAC’s own CRO leaders make. Asia Pacific is now the only region in the world where…
Japan Patients in Japan deserve the same access to innovative treatments that patients in other markets have. Accelerating that access is what drives us Noriyuki Takai, CEO of EPS Corporation, outlines the CRO’s mission to help address Japan’s drug lag and drug loss by supporting faster access to innovative medicines. He…
Japan Hideyasu Matsuda and Toru Fujieda of the Japan CRO Association argue that, thanks to an updated regulatory framework, Japan is becoming one of the most competitive and operationally attractive clinical development destinations in the world. Japan is an attractive clinical trial destination from a cost, quality, and speed perspective…
Korea Kwunho Jeong, CEO of JNPMEDI, is building an integrated clinical development platform that combines proprietary software, CRO services, and biotech investment to strengthen Asia’s drug development ecosystem. A former consultant and fintech executive, he views clinical trials as fundamentally a data management challenge. Through AI, blockchain-based data integrity, and strategic…
APAC Ken Lee, Managing Director for Asia Pacific Clinical Business at Syneos Health, draws on a 20-year career across pharma, medicine, and CROs in Europe and Asia. He highlights Asia Pacific’s shift into a global clinical development hub, the rise of Greater China as a leading source of innovation, with mainland…
China As the global clinical development landscape becomes more fragmented and competitive, biotechs increasingly need partners that can help them navigate regulatory complexity, identify the right trial locations, and generate meaningful data quickly. In this context, Harvest Integrated Research Organization has been expanding its international footprint while positioning itself as a…
China Dr Long Jiang is the CEO of GCP ClinPlus, a Chinese CRO with operations in New Jersey. A former cardiovascular surgeon at Peking University People’s Hospital, he shifted into clinical research after a fellowship at Duke Clinical Research Institute, and later also served as a partner in a private equity firm focusing…
Japan Dr Toshiaki Nagafuji leads the Innovative Drug Development Business (IDDB) at Linical after a career spanning discovery and research at Chugai and clinical development, project management, and business development at Shionogi. At Chugai, he also served as a visiting professor at Brain Research Institute, Niigata University and a visiting researcher…
Korea Jinhak Kim, Executive Director and President US at C&R Research, describes the company’s evolution into a global, data-driven CRO. He outlines its strategy of matching clinical trials to regions based on cost and patient access, expanding into Southeast Asia and the US, integrating AI, and supporting biotechs with end-to-end services…
China Vera Zheng is Head of Greater China and Head of Asia Pacific Strategy at Parexel, one of the world’s leading clinical research organisations. With a career spanning medical marketing, brand strategy, product management and clinical research across multinational and CRO environments, Zheng has built one of the most distinctive leadership…
Taiwan Taiwan’s clinical research ecosystem has evolved rapidly in recent years, reflecting Asia’s growing role in global drug development. Samuel Su, Founder and CEO of Bestat Pharmaservices, discusses how the organisation has expanded from a data-driven CRO into an integrated development partner supporting preclinical research, multi-regional clinical trials, and international regulatory…
See our Cookie Privacy Policy Here
